Magnetic Resonance Imaging of Metastases in Xenograft Mouse Models of Cancer

  • Kersten Peldschus
  • Harald Ittrich
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1070)

Abstract

Magnetic resonance imaging (MRI) of small animals has emerged as a valuable tool to noninvasively monitor tumor growth in mouse models of cancer. However, imaging of metastases in mouse models is difficult due to the need for high spatial resolution. We have demonstrated MRI of metastases in the liver, brain, adrenal glands, and lymph nodes in different xenograft mouse models of cancer. MRI of mice was performed with a clinical 3.0 T magnetic resonance scanner and a commercially available small-animal receiver coil. The imaging protocol consisted of T1- and T2-weighted fat-saturated spin echo sequences with a spatial resolution of 200 μm × 200 μm × 500 μm. Total acquisition time was 30 min per mouse. The technique allowed for repetitive examinations of larger animal cohorts to observe the development of metastases.

Key words

Magnetic resonance imaging (MRI) Xenograft mouse models Small-animal imaging Noninvasive visualization Iron oxide-based contrast agents 

Notes

Acknowledgements

The authors would like to thank Professor Udo Schumacher, Dr. Anka Thies, and Dr. Daniel Benten for providing mouse models with metastases and helpful discussions. Furthermore, Johannes Salamon is acknowledged for technical assistance and image processing.

References

  1. 1.
    Damadian R (1971) Tumor detection by nuclear magnetic resonance. Science 171:1151–1153PubMedCrossRefGoogle Scholar
  2. 2.
    Barentsz J, Takahashi S, Oyen W et al (2006) Commonly used imaging techniques for diagnosis and staging. J Clin Oncol 24:3234–3244PubMedCrossRefGoogle Scholar
  3. 3.
    Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A (2005) Whole-body MR imaging of bone marrow. Eur J Radiol 55:33–40PubMedCrossRefGoogle Scholar
  4. 4.
    Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499PubMedCrossRefGoogle Scholar
  5. 5.
    Koo V, Hamilton PW, Williamson K (2006) Non-invasive in vivo imaging in small animal research. Cell Oncol 28:127–139PubMedGoogle Scholar
  6. 6.
    Poirier-Quinot M, Ginefri JC, Girard O, Robert P, Darrasse L (2008) Performance of a miniature high-temperature superconducting (HTS) surface coil for in vivo microimaging of the mouse in a standard 1.5T clinical whole-body scanner. Magn Reson Med 60:917–927PubMedCrossRefGoogle Scholar
  7. 7.
    Seierstad T, Roe K, Hovik B (2007) Construction of a modified capacitive overlap MR coil for imaging of small animals and objects in a clinical whole-body scanner. Phys Med Biol 52:N513–N522PubMedCrossRefGoogle Scholar
  8. 8.
    Xu S, Gade TP, Matei C et al (2003) In vivo multiple-mouse imaging at 1.5 T. Magn Reson Med 49:551–557PubMedCrossRefGoogle Scholar
  9. 9.
    Linn J, Schwarz F, Schichor C, Wiesmann M (2007) Cranial MRI of small rodents using a clinical MR scanner. Methods 43:2–11PubMedCrossRefGoogle Scholar
  10. 10.
    Inderbitzin D, Stoupis C, Sidler D, Gass M, Candinas D (2007) Abdominal magnetic resonance imaging in small rodents using a clinical 1.5 T MR scanner. Methods 43:46–53PubMedCrossRefGoogle Scholar
  11. 11.
    Garbow JR, Wang M, Wang Y, Lubet RA, You M (2008) Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging. Clin Cancer Res 14:1363–1367PubMedCrossRefGoogle Scholar
  12. 12.
    Lyons SK (2005) Advances in imaging mouse tumour models in vivo. J Pathol 205: 194–205PubMedCrossRefGoogle Scholar
  13. 13.
    Ikehira H, Yamane T, Fukuda N et al (1988) Fundamental tumor perfusion analysis with nuclear magnetic resonance imaging using gadolinium-diethylene triamine pentaacetic acid. Am J Physiol Imaging 3:7–9PubMedGoogle Scholar
  14. 14.
    Checkley D, Tessier JJ, Kendrew J, Waterton JC, Wedge SR (2003) Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer 89: 1889–1895PubMedCrossRefGoogle Scholar
  15. 15.
    Gauvain KM, Garbow JR, Song SK, Hirbe AC, Weilbaecher K (2005) MRI detection of early bone metastases in b16 mouse melanoma models. Clin Exp Metastasis 22:403–411PubMedCrossRefGoogle Scholar
  16. 16.
    Brandsma D, Taphoorn MJ, Reijneveld JC et al (2004) MR imaging of mouse leptomeningeal metastases. J Neurooncol 68:123–130PubMedCrossRefGoogle Scholar
  17. 17.
    Thies A, Peldschus K, Ittrich H et al (2009) Magnetic resonance imaging of melanoma metastases in a clinical relevant human melanoma xenograft scid mouse model. Cancer Lett 274:194–200PubMedCrossRefGoogle Scholar
  18. 18.
    Weber MH, Sharp JC, Latta P, Hassard TH, Orr FW (2007) Early detection and quantification of murine melanoma bone metastases with magnetic resonance imaging. Skeletal Radiol 36:659–666PubMedCrossRefGoogle Scholar
  19. 19.
    Kalber TL, Waterton JC, Griffiths JR, Ryan AJ, Robinson SP (2008) Longitudinal in vivo susceptibility contrast MRI measurements of LS174T colorectal liver metastasis in nude mice. J Magn Reson Imaging 28:1451–1458PubMedCrossRefGoogle Scholar
  20. 20.
    Koyama Y, Talanov VS, Bernardo M et al (2007) A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging 25:866–871PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, New York 2014

Authors and Affiliations

  • Kersten Peldschus
    • 1
  • Harald Ittrich
    • 1
  1. 1.Department of Diagnostic and Interventional RadiologyUniversity Medical Center Hamburg-EppendorfHamburgGermany

Personalised recommendations